Combination treatment with monoclonal antibodies: Dupilumab and ustekinumab for the treatment of severe atopic dermatitis and Crohn disease

We report a case of dual biologic therapy with ustekinumab and dupilumab in a patient with severe Crohn disease and atopic dermatitis. There was no interference between these drugs after a 7-month follow-up.PMID:37929636 | DOI:10.1111/ajd.14185
Source: The Australasian Journal of Dermatology - Category: Dermatology Authors: Source Type: research